RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 40 filers reported holding RENEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,802 | +3.2% | 2,863 | -11.1% | 0.00% | – |
Q2 2023 | $21,123 | +92.0% | 3,220 | -13.4% | 0.00% | – |
Q1 2022 | $11,000 | -73.8% | 3,719 | -23.9% | 0.00% | – |
Q4 2021 | $42,000 | +68.0% | 4,886 | +46.9% | 0.00% | – |
Q3 2021 | $25,000 | -69.1% | 3,327 | -61.9% | 0.00% | – |
Q2 2021 | $81,000 | – | 8,726 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
Ergoteles LLC | 37,640 | $126,000 | 0.00% |
MAI Capital Management | 63,210 | $212,000 | 0.00% |
RBF Capital, LLC | 14,536 | $49,000 | 0.00% |